The Usefulness of Monocyte-to-High Density Lipoprotein and Neutrophil-to-Lymphocyte Ratio in Diabetic Macular Edema Prediction and Early anti-VEGF Treatment Response

• Published in: Ocular immunology and inflammation 2022-05, Vol.30 (4), p.901-906
• Main Authors: Yalinbas Yeter, Duygu, Eroglu, Serap, Sariakcali, Baris, Bozali, Erman, Vural Ozec, Ayse, Erdogan, Haydar
• Format: Article
• Language: English
• Subjects: Diabetes; high-density lipoprotein; inflammation; macular edema; monocyte; retinopathy
• ISSN: 0927-3948; 1744-5078
• DOI: 10.1080/09273948.2020.1849739

To determine the association of monocyte-to-high-density lipoprotein ratio (MHR) and neutrophil-to-lymphocyte ratio (NLR) with diabetic macular edema (DME) and early anti-VEGF treatment response. This was a retrospective and cross-sectional study conducted with 143 patients with diabetes mellitus (53 diabetic retinopathy with DME, 38 diabetic retinopathy without DME, and 52 without diabetic retinopathy). 13.9 was the best cutoff value to predict DME for MHR, and 2 was for NLR (59% and 75% sensitivity and 81% and 59% specificity, respectively). Logistic regression analysis showed that NLR≥2 and MHR≥13.9 were significantly associated with DME prediction. However, neither NLR≥2 nor MHR≥13.9 was associated with central retinal thickness(CRT) or best corrected visual acuity(BCVA) outcomes after anti-VEGF treatment. On the other hand, increased NLR was associated with inferior CRT outcomes. MHR and NLR were simple and cost-effective biomarkers to predict DME. Moreover, higher NLR may contribute to poor CRT outcomes.